Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection.

He, Chao

Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection. [electronic resource] - Medicine Apr 2017 - e6606 p. digital

Publication Type: Journal Article; Observational Study

1536-5964

10.1097/MD.0000000000006606 doi


Adult
Age Factors
Aged
Antineoplastic Agents--administration & dosage
Carcinoma, Hepatocellular--drug therapy
Chemotherapy, Adjuvant--methods
Comorbidity
Disease-Free Survival
Female
Humans
Liver Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Prognosis
Proportional Hazards Models
Retrospective Studies
Sex Factors
Thymalfasin
Thymosin--administration & dosage
Young Adult